Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Key Facts on Billing Drug Wastage

From the College  |  January 24, 2023

Key Billing Guidelines

  • Ensure drug amounts administered to patients are accurately reported in terms of the dosage specified in the long descriptor for the applicable HCPCS codes. The short descriptors are limited to 28 characters, so they do not always capture the complete drug description.
  • When submitting Medicare claims, units of service should be reported in multiples of the dosage included in the long HCPCS code descriptor. If the amount given is not a multiple of the number provided in the HCPCS code description, the provider should round up to the nearest whole multiple of the described dosage.
  • If the provider must discard the remainder of a single-use vial or other package after administering the prescribed dosage of any given drug, Medicare may cover the amount of the drug discarded along with the amount administered. The following elements must be followed for the discarded amount to be covered. 
    1. The vial must be a single-use vial. Multi-use vials are not eligible for payment of any discarded drug amounts.
    2. The units billed should, where possible, correspond with the smallest dose (or vial) available for purchase from the manufacturer(s) that could provide the appropriate dose for the patient, while minimizing wastage.
    3. Any amount of drug billed as wastage from a single-dose vial must be discarded and may not be used for another patient, regardless of whether or not that other patient has Medicare.
  • Providers should clearly document in the patient’s medical record the actual dose administered in addition to the exact amount wasted and the total amount the vial is labeled to contain. Detailed documentation will help practices justify billing of wasted drug in the event of a medical review.
  • Medicare requires discarded drugs be reported with the JW modifier on a separate line. The total number of discarded units reported should not include amounts of the drug also included on the administered line due to rounding.
  • Verify the amount of drug administered to the patient, then convert that amount to the proper units for billing.

To submit a waste-required claim, providers must submit two complete claim lines.

  1. Claim line #1 should include: 
  • HCPCS code for drug given;
  • No modifier;
  • Number of units given to the patient; and
  • Calculated submitted price for ONLY the amount of drug given.
  1. Claim line #2 should include:
  • HCPCS code for drug wasted;
  • JW modifier to indicate waste;
  • Number of units wasted; and
  • Calculated submitted price for ONLY the amount of drug wasted.

Billing Examples

Example #1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Billing/Coding Tagged with:Billing & Coding

Related Articles

    New HCPCS Modifiers Replace -59 on January 1, 2015

    December 1, 2014

    Referred to as -X modifiers, they are designed to define specific subsets of -59 modifier

    Rheumatology Coding Corner Answer: Billing Infusion Procedure with JW Modifier

    April 20, 2017

    Take the challenge. CPT: 99214-25, 96413, 96375, 96361-59, J1745 x 4 J1745 JW* x 36, J1200 x1 ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEICD-10: M45.09, T50.995A, R06.02, E66.3, Z68.2 Rationale Modifier 25 is appropriate to use because it indicates the patient received a significant, separately identifiable E/M service on the same day as the infliximab infusion. This…

    Coding Corner Answer: March

    March 1, 2015

    Coding for chemotherapy infusion with a drug reaction

    Coding Corner Answer: A Quiz on Modifiers

    February 18, 2019

    Take the challenge. 1. A—Modifier -25 is defined as a significant, separately identifiable evaluation and management (E/M) service by the same physician or other qualified healthcare professional on the same day of the procedure or other service. It is to be placed on the E/M visit only because it attests to the payer there is…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences